Kissei Pharmaceutical is forecast to grow earnings and revenue by 0.7% and 2.9% per annum respectively. EPS is expected to grow by 3.9% per annum. Return on equity is forecast to be 6.3% in 3 years.
Key information
0.7%
Earnings growth rate
3.90%
EPS growth rate
Pharmaceuticals earnings growth
14.4%
Revenue growth rate
2.9%
Future return on equity
6.33%
Analyst coverage
Good
Last updated
04 Jun 2026
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
OTCPK:KSPH.F - Analysts future estimates and past financials data (JPY Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
3/31/2029
104,491
12,178
8,551
10,052
6
3/31/2028
100,057
11,847
8,261
9,134
6
3/31/2027
93,734
9,540
10,014
9,099
6
3/31/2026
97,406
13,779
-7,121
-1,485
N/A
12/31/2025
95,294
14,135
N/A
N/A
N/A
9/30/2025
91,695
14,496
5,532
11,733
N/A
6/30/2025
89,357
12,374
N/A
N/A
N/A
3/31/2025
88,330
11,961
1,491
6,521
N/A
12/31/2024
83,389
11,663
N/A
N/A
N/A
9/30/2024
81,067
10,731
291
3,431
N/A
6/30/2024
77,430
12,001
N/A
N/A
N/A
3/31/2024
75,579
11,160
-3,510
-1,677
N/A
12/31/2023
73,717
12,198
N/A
N/A
N/A
9/30/2023
71,607
12,880
-8,350
-5,854
N/A
6/30/2023
70,521
12,158
N/A
N/A
N/A
3/31/2023
67,493
10,528
-9,226
-6,679
N/A
12/31/2022
66,931
12,769
N/A
N/A
N/A
9/30/2022
65,857
10,581
-4,543
-2,556
N/A
6/30/2022
65,031
10,912
N/A
N/A
N/A
3/31/2022
65,381
12,921
-386
1,533
N/A
12/31/2021
66,934
5,664
N/A
N/A
N/A
9/30/2021
69,148
6,555
-2,042
-349
N/A
6/30/2021
69,618
7,204
N/A
N/A
N/A
3/31/2021
69,044
5,285
-4,027
-2,542
N/A
12/31/2020
66,877
5,715
N/A
N/A
N/A
9/30/2020
63,970
5,063
-573
683
N/A
6/30/2020
63,196
2,530
N/A
N/A
N/A
3/31/2020
63,234
2,817
12,632
13,934
N/A
12/31/2019
65,594
4,753
N/A
N/A
N/A
9/30/2019
68,180
4,294
N/A
10,431
N/A
6/30/2019
70,545
4,752
N/A
N/A
N/A
3/31/2019
72,297
5,481
N/A
6,346
N/A
12/31/2018
72,474
5,263
N/A
N/A
N/A
9/30/2018
73,087
8,102
N/A
13,854
N/A
6/30/2018
73,014
9,685
N/A
N/A
N/A
3/31/2018
74,009
9,045
N/A
8,845
N/A
12/31/2017
73,887
8,735
N/A
N/A
N/A
9/30/2017
72,459
8,116
N/A
5,756
N/A
6/30/2017
71,396
6,993
N/A
N/A
N/A
3/31/2017
71,706
7,726
N/A
6,441
N/A
12/31/2016
72,154
6,401
N/A
N/A
N/A
9/30/2016
73,533
8,108
N/A
9,023
N/A
6/30/2016
73,774
8,734
N/A
N/A
N/A
3/31/2016
71,294
8,165
N/A
5,763
N/A
12/31/2015
71,239
8,521
N/A
N/A
N/A
9/30/2015
69,095
6,608
N/A
2,948
N/A
6/30/2015
70,945
7,161
N/A
N/A
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KSPH.F's forecast earnings growth (0.7% per year) is below the savings rate (3.5%).
Earnings vs Market: KSPH.F's earnings (0.7% per year) are forecast to grow slower than the US market (17.1% per year).
High Growth Earnings: KSPH.F's earnings are forecast to grow, but not significantly.
Revenue vs Market: KSPH.F's revenue (2.9% per year) is forecast to grow slower than the US market (11.9% per year).
High Growth Revenue: KSPH.F's revenue (2.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: KSPH.F's Return on Equity is forecast to be low in 3 years time (6.3%).
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/10 11:27
End of Day Share Price
2026/03/13 00:00
Earnings
2026/03/31
Annual Earnings
2026/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kissei Pharmaceutical Co., Ltd. is covered by 16 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.